ACTU
ACTUATE THERAPEUTICS, INC.
NASDAQ · Healthcare · Biotechnology · US
$0.96
−3.52%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$0.18
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 14, 2026
- EPS actual
- -$0.20
- EPS estimate
- -$0.21
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 3
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +8.2%
- Revenue beats (12Q)
- —
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $11
- PT range
- $6.00 – $15
- Analysts
- 2
2 Buy0 Hold0 Sell
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 14, 2026 | -$0.21 | -$0.20 | Beat 4.76% | — |
| May 14, 2026 | -$0.23 | -$0.24 | Miss -4.35% | — |
| Mar 26, 2026 | -$0.24 | -$0.18 | Beat 25.00% | — |
| Nov 13, 2025 | -$0.27 | -$0.25 | Beat 7.41% | — |
| Aug 14, 2025 | -$0.19 | -$0.30 | Miss -57.89% | — |
| May 15, 2025 | -$0.30 | -$0.32 | Miss -6.67% | — |
| Mar 13, 2025 | -$0.29 | -$0.33 | Miss -13.79% | — |
| Sep 24, 2024 | — | -$4.20 | — | — |
| Mar 31, 2024 | — | -$0.54 | — | — |
| Dec 31, 2023 | — | -$0.50 | — | — |
| Sep 30, 2023 | — | -$0.41 | — | — |
| Jun 30, 2023 | — | -$0.39 | — | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026